These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23817430)

  • 1. Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8.
    Ireland R; Wang R; Alinger JB; Small P; Bosio CM
    J Immunol; 2013 Aug; 191(3):1276-86. PubMed ID: 23817430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis.
    Bauler TJ; Chase JC; Bosio CM
    J Immunol; 2011 Aug; 187(4):1845-55. PubMed ID: 21753150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo.
    Chase JC; Bosio CM
    Infect Immun; 2010 Jan; 78(1):154-67. PubMed ID: 19841074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
    Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
    Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
    Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS
    PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response.
    Mahawar M; Atianand MK; Dotson RJ; Mora V; Rabadi SM; Metzger DW; Huntley JF; Harton JA; Malik M; Bakshi CS
    J Biol Chem; 2012 Jul; 287(30):25216-29. PubMed ID: 22654100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
    Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
    mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.
    Crane DD; Scott DP; Bosio CM
    PLoS One; 2012; 7(3):e33349. PubMed ID: 22428026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
    Zhang P; Katz J; Michalek SM
    Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
    Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
    Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.
    Crane DD; Warner SL; Bosio CM
    J Immunol; 2009 Oct; 183(7):4593-600. PubMed ID: 19752236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.
    Steiner DJ; Furuya Y; Metzger DW
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia.
    Periasamy S; Singh A; Sahay B; Rahman T; Feustel PJ; Pham GH; Gosselin EJ; Sellati TJ
    J Leukoc Biol; 2011 Sep; 90(3):493-507. PubMed ID: 21724804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of inflammasome by Francisella tularensis during early stages of infection.
    Dotson RJ; Rabadi SM; Westcott EL; Bradley S; Catlett SV; Banik S; Harton JA; Bakshi CS; Malik M
    J Biol Chem; 2013 Aug; 288(33):23844-57. PubMed ID: 23821549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella species.
    Griffin AJ; Crane DD; Wehrly TD; Scott DP; Bosio CM
    PLoS One; 2013; 8(12):e82096. PubMed ID: 24324751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.
    Gentry M; Taormina J; Pyles RB; Yeager L; Kirtley M; Popov VL; Klimpel G; Eaves-Pyles T
    Infect Immun; 2007 Aug; 75(8):3969-78. PubMed ID: 17502386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
    Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
    Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.
    Rawool DB; Bitsaktsis C; Li Y; Gosselin DR; Lin Y; Kurkure NV; Metzger DW; Gosselin EJ
    J Immunol; 2008 Apr; 180(8):5548-57. PubMed ID: 18390739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.
    Rockx-Brouwer D; Chong A; Wehrly TD; Child R; Crane DD; Celli J; Bosio CM
    PLoS One; 2012; 7(5):e37752. PubMed ID: 22662210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.